United Kingdom

The United Kingdom is represented in JPIAMR by the Medical Research Council (MRC).

The MRC is a publicly-funded organisation dedicated to improving human health. Research into combating antimicrobial resistance remains a priority to MRC and is currently funded by response-mode grants, fellowships and strategic initiatives.

National AMR research program and activities

AMR Research program

• UKRI AMR Initiative; launched 2014
• Global AMR Innovation Fund (GAMRIF); launched 2016
Fleming Fund; launched 2016
National PhD Training Programme in AMR; Medical Research Foundation (MRF)
• AMR Structured Operational Research and Training Initiative (AMR SORT IT); January 2019 – December 2022 NIHR with UNICEF/UNDP/ World Bank/ WHO
• UK Food Standards Agency AMR Programme

National AMR research calls

• China-UK AMR Partnership Hubs 2018; March 2018; MRC/UKRI; academic led
• UK-China collaboration to tackle AMR; April 2018; Innovate/GAMRIF; industry led
• JPIAMR Surveillance network call; launched May 2018; MRC for UK-led networks
• JPIAMR VRI network call; launched May 2018; MRC for UK-led networks
• Review of the impact of food processing on AMR in meat & meat products; FSA June 2018
• Burden of antimicrobial resistance genes in selected ready-to-eat foods; FSA August 2018
• Capital call to support AMR research; NIHR October 2018
• BBSRC/NERC-CONICET Joint Awards for AMR in the Environment; launched November 1st 2018
• Health Protection Research Unit in healthcare associated infections and AMR; NIHR March 2019
• UK-India tackling AMR in the environment from antimicrobial manufacturing waste; May 2019
• UK-South Africa AMR Drug Discovery Hub call; June 2019

Activities on AMR actions at national level

• AMR Research to Policy Workshop; July 2018 London UK
• Annual AMR Residential PhD Training course
• AMR Call to Action Summit; November 2018 Accra Ghana
• AMR Panel Event in Parliament; February 2019
Tackling AMR National Campaign; March 2019
• UK-India tackling AMR in the environment from antimicrobial manufacturing waste; May 2019
• UK-South Africa AMR Drug Discovery Workshop; June 2019
• UK antibiotic procurement model launched June 2020
• Acquired carbapenemase-producing Gram-negative bacteria added to the list of organisms in the UK requiring statutory notification (July 2020).
• UK AMR Public Consultation – Webinar series Sept 2020

 

National AMR action plans

• UK’s five-year NAP: Tackling antimicrobial resistance 2019-2024; 24th January 2019
• UK’s 20-year vision for AMR: Contained and Controlled; 24th January 2019

 

Management Board representatives

  • Jessica Boname, UKRI Medical Research Council
  • Jonathan Pearce, UKRI Medical Research Council